The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
Pharmacists dispensing cannabis, healthcare professionals' potential conflicts of interest and youth use were all covered in the first review of the impacts of legalization.
Health officials say they analyzed a number of white triangular pills with rounded corners that resemble eight-milligram hydromorphone pills that are sold under the brand name Dilaudid.
